See also this year's filing and all EDGAR filings for this company.
PDF Report 0001506251_2024_Citius_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001506251, Citius Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 34,370,434 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 9,346,796 |
| 2 | PropertyPlantAndEquipmentNet | 1,432 |
| 3 | remainder_Assets | 59,892,488 |
| 4 | LiabilitiesCurrent | 5,778,997 |
| 5 | LiabilitiesNoncurrent | 262,865 |
| 6 | remainder_Liabilities | 6,137,800 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,906,861 |
| 9 | ResearchAndDevelopmentExpense | 15,417,080 |
| 10 | remainder_Expenses | 10,183,157 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,628,698 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 103,611,150 |
| 1 | Liabilities | 12,179,662 |
| 2 | Expenses | 50,507,098 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 91,431,488 |
| 5 | NetIncome | -45,878,400 |
| 6 | ComprehensiveNetIncome | -45,878,400 |
| 7 | BaseVar | 85,463,304 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.65 |
| 9 | EconomicCapitalRatio | 3.45 |
Edgar->Model Mapping
Feature Distribution
Change over Time
